EUVIMEDEUVIMED entdecken
Open Access

Circulating Sphingolipids and All‐Cause Mortality: The Strong Heart Family Study

Amanda M Fretts iD, Paul N Jensen iD, Colleen M Sitlani iD, Andy Hoofnagle iD, Benjamin Lidgard iD, Jason G Umans iD, David S Siscovick iD, Irena B King iD, Barbara V Howard iD, Shelley A Cole iD, Rozenn N Lemaitre iD

Journal of the American Heart Association · 02.07.2024 · 13 (13)

DOI: 10.1161/jaha.123.032536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 02.07.2024. Verfasst von Amanda M Fretts und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology University of Washington Seattle WA USA. Hauptthemen laut MEDLINE: Ceramides, Sphingomyelins, Sphingolipids, Cause of Death. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A growing body of research indicates that associations of ceramides and sphingomyelins with mortality depend on the chain length of the fatty acid acylated to the backbone sphingoid base. We examined associations of 8 ceramide and sphingomyelin species with mortality among an American Indian population. Methods and Results The analysis comprised 2688 participants from the SHFS (Strong Heart Family Study). Plasma ceramide and sphingomyelin species carrying long‐chain (ie, 16:0) and very‐long‐chain (ie, 20:0, 22:0, 24:0) saturated fatty acids were measured by sequential liquid chromatography and mass spectroscopy using samples from 2001 to 2003. Participants were followed for 18.8 years (2001–2020). Associations of ceramides and sphingomyelins with mortality were assessed using Cox models. The mean age of participants was 40.8 years. There were 574 deaths during a median 17.4‐year follow‐up. Ceramides and sphingomyelins carrying fatty acid 16:0 were positively associated with mortality. Ceramides and sphingomyelins carrying longer fatty acids were inversely associated with mortality. Per SD difference in each ceramide and sphingomyelin species, hazard ratios for death were: 1.68 (95% CI, 1.44–1.96) for ceramide‐16 (Cer‐16), 0.82 (95% CI, 0.71–0.95) for Cer‐20, 0.60 (95% CI, 0.51–0.70) for Cer‐22, 0.67 (95% CI, 0.56–0.79) for Cer‐24, 1.80 (95% CI–1.57, 2.05) for sphingomyelin‐16 (SM‐16), 0.54 (95% CI, 0.47–0.62) for SM‐20, 0.50 (95% CI, 0.44–0.57) for SM‐22, and 0.59 (95% CI, 0.52–0.67) for SM‐24.

Conclusions

The direction/magnitude of associations of ceramides and sphingomyelins with mortality differs according to the length of the fatty acid acylated to the backbone sphingoid base. Registration URL: https://www.clinicatrials.gov ; Unique identifier: NCT00005134.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeramidesSphingomyelinsSphingolipidsCause of DeathHumansMaleFemaleAdultMiddle AgedUnited StatesBiomarkersRisk FactorsAmerican Indian or Alaska NativeFatty AcidsRisk Assessment

Stichwörter der Autor:innen

American Indianceramidesmortalitysphingolipidssphingomyelins

Substanzen

CeramidesSphingomyelinsSphingolipidsBiomarkersFatty Acids

Autor:innen und Institutionen

  • Department of Epidemiology University of Washington Seattle WA USA.
  • Cardiovascular Health Research Unit University of Washington Seattle WA USA.
  • Department of Medicine University of Washington Seattle WA USA.
  • Department of Laboratory Medicine University of Washington Seattle WA USA.
  • Department of Nephrology University of Washington Seattle Washington USA.
  • MedStar Health Research Institute Hyattsville MD USA.

ORCID-Profile: Amanda M Fretts, Paul N Jensen, Colleen M Sitlani, Andy Hoofnagle, Benjamin Lidgard, Jason G Umans, David S Siscovick, Irena B King, Barbara V Howard, Shelley A Cole, Rozenn N Lemaitre

Förderung

  • NHLBI NIH HHS
  • NIH HHS

Zitieren

APA

Fretts, A. M., Jensen, P. N., Sitlani, C. M., Hoofnagle, A., Lidgard, B., Umans, J. G., Siscovick, D. S., King, I. B., Howard, B. V., Cole, S. A., & Lemaitre, R. N. (2024). Circulating Sphingolipids and All‐Cause Mortality: The Strong Heart Family Study. Journal of the American Heart Association, 13(13). https://doi.org/10.1161/jaha.123.032536

Vancouver

Fretts AM, Jensen PN, Sitlani CM, Hoofnagle A, Lidgard B, Umans JG, et al. Circulating Sphingolipids and All‐Cause Mortality: The Strong Heart Family Study. Journal of the American Heart Association. 2024;13(13). doi:10.1161/jaha.123.032536

BibTeX
@article{Fretts2024,
  author = {Fretts, Amanda M and Jensen, Paul N and Sitlani, Colleen M and Hoofnagle, Andy and Lidgard, Benjamin and Umans, Jason G and Siscovick, David S and King, Irena B and Howard, Barbara V and Cole, Shelley A and Lemaitre, Rozenn N},
  title = {Circulating Sphingolipids and All‐Cause Mortality: The Strong Heart Family Study},
  journal = {Journal of the American Heart Association},
  year = {2024},
  volume = {13},
  number = {13},
  doi = {10.1161/jaha.123.032536}
}
Kostenlos starten →